EPIVIR - lamivudine
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC| Field | Value |
|---|---|
| NDC Code: | 0173-0470 |
| Proprietary Name: | EPIVIR |
| Suffix: | |
| Non-Proprietary Name: | lamivudine |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 21-11-1995 |
| End of Marketing: | 16-06-2015 |
| Category Name: | NDA |
| Application Number: | NDA020564 |
| Labeler: | GLAXOSMITHKLINE LLC |
| Substance Name: | LAMIVUDINE |
| Active Numerator Strength: | 150 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |